SEC Form 424B4 filed by Qualigen Therapeutics Inc. - Quantisnow
Qualigen Therapeutics, Inc. is offering 14,724,058 shares of common stock and 11,972,754 pre-funded warrants to purchase up to 11,972,754 shares of common stock at $0.13 per share. The offering is on a 'reasonable best efforts' basis, with no minimum required. The net proceeds will be used for operations, clinical trials, and other corporate purposes. The common stock is listed on The Nasdaq Capital Market under the symbol 'QLGN'.
Related News
Qualigen Therapeutics, Inc. is offering 14,724,058 shares of common stock and 11,972,754 pre-funded warrants to purchase up to 11,972,754 shares of common stock at $0.13 per share. The offering is on a 'reasonable best efforts' basis, with no minimum required. The net proceeds will be used for operations, clinical trials, and other corporate purposes. The common stock is listed on The Nasdaq Capital Market under the symbol 'QLGN'.